The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial
Open accessAbstract
Background: Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial fibrillation (AF) ablation. Methods: We randomly assigned 346 patients with drug-refractory paroxysmal AF to contact force–guided radiofrequency ablation (CF-RF; n=115), 4-minute cryoballoon ablation (Cryo-4; n=115), or 2-minute cryoballoon ablation (Cryo-2; n=116). Follow-up was 12 months. The primary outcome was time to first documented recurrence of symptomatic or asymptomatic atrial tachyarrhythmia (AF, atrial flutter, or atrial tachycardia) between days 91 and 365 after ablation or a repeat ablation procedure at any time. Secondary end points included freedom from symptomatic arrhythmia and AF burden. All patients received an implantable loop recorder. Results: One-year freedom from atrial tachyarrhythmia defined by continuous rhythm monitoring was 53.9%, 52.2%, and 51.7% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.87). One-year freedom from symptomatic atrial tachyarrhythmia defined by continuous rhythm monitoring was 79.1%, 78.2%, and 73.3% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.26). Compared with the monitoring period before ablation, AF burden was reduced by a median of 99.3% (interquartile range, 67.8%–100.0%) with CF-RF, 99.9% (interquartile range, 65.3%–100.0%) with Cryo-4, and 98.4% (interquartile range, 56.2%–100.0%) with Cryo-2 ( P =0.36). Serious adverse events occurred in 3 patients (2.6%) in the CF-RF group, 6 patients (5.3%) in the Cryo-4 group, and 7 patients (6.0%) in the Cryo-2 group, with no significant difference between groups ( P =0.24). The CF-RF group had a significantly longer procedure duration but significantly shorter fluoroscopy exposure ( P <0.001 vs cryoballoon groups). Conclusions: In this multicenter, randomized, single-blinded trial, CF-RF and 2 different regimens of cryoballoon ablation resulted in no difference in 1-year efficacy, which was 53% by time to first recurrence but >98% burden reduction as assessed by continuous cardiac rhythm monitoring. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01913522.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,755
Self-citationCryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Kuck, K.-H., Brugada, J., Fürnkranz, A., Metzner, A., Ouyang, F., Chun, K. R. J., Elvan, A., Arentz, T., Bestehorn, K., Pocock, S. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602014 · Cited by 1,950
Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Self-citationCryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation
Packer, D. L., Kowal, R. C., Wheelan, K. R., Irwin, J. M., Champagne, J., Guerra, P. G., Dubuc, M., Reddy, V., Nelson, L., Holcomb, R. G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.064 · Cited by 899
Self-citationCatheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study
Jaïs, P., Cauchemez, B., Macle, L., Daoud, E., Khairy, P., Subbiah, R., Hocini, M., Extramiana, F., Sacher, F., Bordachar, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772582 · Cited by 891
Self-citationReddy, V. Y., Shah, D., Kautzner, J., Schmidt, B., Saoudi, N., Herrera, C., Jaïs, P., Hindricks, G., Peichl, P., Yulzari, A., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.07.016 · Cited by 484
Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter
Natale, A., Reddy, V. Y., Monir, G., Wilber, D. J., Lindsay, B. D., McElderry, H. T., Kantipudi, C., Mansour, M. C., Melby, D. P., Packer, D. L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.072 · Cited by 472
Chen, L. Y., Chung, M. K., Allen, L. A., Ezekowitz, M., Furie, K. L., McCabe, P., Noseworthy, P. A., Perez, M. V., & Turakhia, M. P. (2018) · Circulation · doi:10.1161/cir.0000000000000568 · Cited by 439
Neuzil, P., Reddy, V. Y., Kautzner, J., Petru, J., Wichterle, D., Shah, D., Lambert, H., Yulzari, A., Wissner, E., & Kuck, K.-H. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000374 · Cited by 434
Reddy, V. Y., Dukkipati, S. R., Neuzil, P., Natale, A., Albenque, J.-P., Kautzner, J., Shah, D., Michaud, G., Wharton, M., Harari, D., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014092 · Cited by 383
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
Reddy, V. Y., Gerstenfeld, E. P., Natale, A., Whang, W., Cuoco, F. A., Patel, C., Mountantonakis, S. E., Gibson, D. N., Harding, J. D., Ellis, C. R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307291 · Cited by 970
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
Andrade, J. G., Wells, G. A., Deyell, M. W., Bennett, M., Essebag, V., Champagne, J., Roux, J.-F., Yung, D., Skanes, A., Khaykin, Y., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029980 · Cited by 822
Self-citationPulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial
Verma, A., Haines, D. E., Boersma, L. V., Sood, N., Natale, A., Marchlinski, F. E., Calkins, H., Sanders, P., Packer, D. L., Kuck, K.-H., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.063988 · Cited by 613
Self-citationAndrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Self-citation
Metadata
- Authors
- Andrade, J. G., Champagne, J., Dubuc, M., Deyell, M. W., Verma, A., Macle, L., Leong-Sit, P., Novak, P., Badra-Verdu, M., Sapp, J., Mangat, I., Khoo, C., Steinberg, C., Bennett, M. T., Tang, A. S. L., Khairy, P., For the CIRCA-DOSE Study Investigators, Parkash, R., Guerra, P., Dyrda, K., Rivard, L., Racine, N., Sterns, L., Leather, R., Seifer, C., Jolly, U., Raymond, J.-M., Roux, J.-F., Nault, I., Sarrazin, J.-F., Ramanathan, K., Cheung, C., Fordyce, C., McKinney, J., Luong, C., Rizkallah, J., Angaran, P., Ha, A., Glover, B., Skanes, A., & Gula, L.
- Venue
- Circulation
- Published
- 2019-11-26
- Volume
- 140
- Issue
- 22
- Pages
- 1779-1788
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2981584498
- Cited by
- 570
- References
- 25
- FWCI
- 43.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1161/circulationaha.119.042622
- The paper
- Andrade, J. G., Champagne, J., Dubuc, M., Deyell, M. W., Verma, A., Macle, L., Leong-Sit, P., Novak, P., Badra-Verdu, M., Sapp, J., Mangat, I., Khoo, C., Steinberg, C., Bennett, M. T., Tang, A. S. L., Khairy, P., For the CIRCA-DOSE Study Investigators, Parkash, R., Guerra, P., . . . Gula, L. (2019). Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation. https://doi.org/10.1161/circulationaha.119.042622
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.